Steven Sloan, MD, PhD

Blood Bank Medical Director

Assistant Professor of Pathology, Harvard Medical School

    Contact: 617-355-6347
  • Fax: 617-730-0383

Medical Services


  • Transfusion Medicine


  • English
To schedule an appointment: Call 617-355-6347

Experience and Education


Medical School

New York University School of Medicine, 1990

New York City, NY


Hospital of the University of Pennsylvania, 1990-1994

Philadelphia, PA


Hospital of the University of Pennsylvania, 1994-1996

Philadelphia, PA


  • American Board of Pathology, Pathology-Clinical, Blood Banking/Transfusion Medicine


Publications powered by Harvard Catalyst Profiles
  1. Yazer MH, Waters JH, Spinella PC, Cap CA, Fahie CRL, Gourdine E, Jenkins DH, Kleinman S, Moore EE, Ness P, Shinar E, Sloan SR, Stubbs JR, Ward KR. Use of Uncrossmatched Erythrocytes in Emergency Bleeding Situations. Anesthesiology. 2017 Dec 15.
  2. Yazer MH, Seheult J, Kleinman S, Sloan SR, Spinella PC. Who's afraid of incompatible plasma? A balanced approach to the safe transfusion of blood products containing ABO-incompatible plasma. Transfusion. 2018 Feb; 58(2):532-538.
  3. Sloan SR. The Potential and Pitfalls of a Dye-Assisted Paper-Based Assay for Blood Grouping. Clin Chem. 2017 Oct 16.
  4. Delaney M, Stark PC, Suh M, Triulzi DJ, Hess JR, Steiner ME, Stowell CP, Sloan SR. Massive Transfusion in Cardiac Surgery: The Impact of Blood Component Ratios on Clinical Outcomes and Survival. Anesth Analg. 2017 06; 124(6):1777-1782.
  5. Sloan SR. The importance of antibody screens after transfusions. Transfusion. 2016 Nov; 56(11):2653-2654.
  6. Sloan SR, Parker RI. Current Status of Platelet Transfusion in Pediatric Patients. Transfus Med Rev. 2016 Oct; 30(4):230-4.
  7. Dunbar NM, Raval JS, Johnson A, Abikoff CM, Adamski J, Cooling LL, Grossman B, Kim HC, Marques MB, Morgan S, Schmidt AE, Sloan SR, Su LL, Szczepiorkowski ZM, West FB, Wong E, Schneiderman J. Extracorporeal photopheresis practice patterns: An international survey by the ASFA ECP subcommittee. J Clin Apher. 2017 Aug; 32(4):215-223.
  8. Price TH, Boeckh M, Harrison RW, McCullough J, Ness PM, Strauss RG, Nichols WG, Hamza TH, Cushing MM, King KE, Young JA, Williams E, McFarland J, Holter Chakrabarty J, Sloan SR, Friedman D, Parekh S, Sachais BS, Kiss JE, Assmann SF. Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection. Blood. 2015 Oct 29; 126(18):2153-61.
  9. Steiner ME, Ness PM, Assmann SF, Triulzi DJ, Sloan SR, Delaney M, Granger S, Bennett-Guerrero E, Blajchman MA, Scavo V, Carson JL, Levy JH, Whitman G, D'Andrea P, Pulkrabek S, Ortel TL, Bornikova L, Raife T, Puca KE, Kaufman RM, Nuttall GA, Young PP, Youssef S, Engelman R, Greilich PE, Miles R, Josephson CD, Bracey A, Cooke R, McCullough J, Hunsaker R, Uhl L, McFarland JG, Park Y, Cushing MM, Klodell CT, Karanam R, Roberts PR, Dyke C, Hod EA, Stowell CP. Effects of red-cell storage duration on patients undergoing cardiac surgery. N Engl J Med. 2015 Apr 09; 372(15):1419-29.
  10. Sloan SR, Andrzejewski C, Aqui NA, Kiss JE, Krause PJ, Park YA. Role of therapeutic apheresis in infectious and inflammatory diseases: Current knowledge and unanswered questions. J Clin Apher. 2015 Oct; 30(5):259-64.
  11. Show all
  12. Ratcliffe N, Dunbar NM, Adamski J, Couriel D, Edelson R, Kitko CL, Levine JE, Morgan S, Schneiderman J, Sloan S, Wu Y, Szczepiorkowski ZM, Cooling L. National Institutes of Health State of the Science Symposium in Therapeutic Apheresis: scientific opportunities in extracorporeal photopheresis. Transfus Med Rev. 2015 Jan; 29(1):62-70.
  13. Josephson CD, Mondoro TH, Ambruso DR, Sanchez R, Sloan SR, Luban NL, Widness JA. One size will never fit all: the future of research in pediatric transfusion medicine. Pediatr Res. 2014 Nov; 76(5):425-31.
  14. Callum JL, Waters JH, Shaz BH, Sloan SR, Murphy MF. The AABB recommendations for the Choosing Wisely campaign of the American Board of Internal Medicine. Transfusion. 2014 Sep; 54(9):2344-52.
  15. Liew WK, Powell CA, Sloan SR, Shamberger RC, Weldon CB, Darras BT, Kang PB. Comparison of plasmapheresis and intravenous immunoglobulin as maintenance therapies for juvenile myasthenia gravis. JAMA Neurol. 2014 May; 71(5):575-80.
  16. Valentine SL, Lightdale JR, Tran CM, Jiang H, Sloan SR, Kleinman ME, Randolph AG. Assessment of hemoglobin threshold for packed RBC transfusion in a medical-surgical PICU. Pediatr Crit Care Med. 2014 Feb; 15(2):e89-94.
  17. Kim YA, Sloan SR. Pediatric therapeutic apheresis: rationale and indications for plasmapheresis, cytapheresis, extracorporeal photopheresis, and LDL apheresis. Pediatr Clin North Am. 2013 Dec; 60(6):1569-80.
  18. Delaney M, Capocelli KE, Eder AF, Schneiderman J, Schwartz J, Sloan SR, Wong EC, Kim HC. An international survey of pediatric apheresis practice. J Clin Apher. 2014 Apr; 29(2):120-6.
  19. Samnaliev M, Tran CM, Sloan SR, Gasior I, Lightdale JR, Brustowicz RM. Economic evaluation of cell salvage in pediatric surgery. Paediatr Anaesth. 2013 Nov; 23(11):1027-34.
  20. Sloan SR, Steiner ME, Stowell CP, Assmann SF, Delaney M, Triulzi D. Current randomized clinical trials of red cell storage duration and patient outcomes. Crit Care Med. 2012 Oct; 40(10):2927; author reply 2927-8.
  21. Josephson CD, Granger S, Assmann SF, Castillejo MI, Strauss RG, Slichter SJ, Steiner ME, Journeycake JM, Thornburg CD, Bussel J, Grabowski EF, Neufeld EJ, Savage W, Sloan SR. Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia. Blood. 2012 Jul 26; 120(4):748-60.
  22. Ambruso DR, Sanchez R, Sloan SR, Josephson CD. How do we teach pediatric topics in transfusion medicine: curriculum development, learners, and instructional strategies. Transfusion. 2013 Feb; 53(2):250-6.
  23. Sloan SR. Tolerant heaven or mHEL trouble. Blood. 2012 Feb 09; 119(6):1330-1.
  24. Sloan SR. Transfusions for patients with sickle cell disease at Children's Hospital Boston. Immunohematology. 2012; 28(1):17-9.
  25. Lightdale JR, Randolph AG, Tran CM, Jiang H, Colon A, Houlahan K, Billet A, Sloan S, Lehmann LE. Impact of a conservative red blood cell transfusion strategy in children undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2012 May; 18(5):813-7.
  26. Campbell Lee S, Shaz B, Arena R, Sloan S, Fung M, Ramsey G. Red blood cell products: consideration of the discrepant temperature ranges permitted for storage versus transport. Transfusion. 2012 Jan; 52(1):195-200.
  27. Sloan SR. Neonatal transfusion review. Paediatr Anaesth. 2011 Jan; 21(1):25-30.
  28. Spinella PC, Dressler A, Tucci M, Carroll CL, Rosen RS, Hume H, Sloan SR, Lacroix J. Survey of transfusion policies at US and Canadian children's hospitals in 2008 and 2009. Transfusion. 2010 Nov; 50(11):2328-35.
  29. Shaikh S, Sloan SR. Clearance of maternal isohemagglutinins from infant circulation (CME). Transfusion. 2011 May; 51(5):938-42.
  30. Steiner ME, Assmann SF, Levy JH, Marshall J, Pulkrabek S, Sloan SR, Triulzi D, Stowell CP. Addressing the question of the effect of RBC storage on clinical outcomes: the Red Cell Storage Duration Study (RECESS) (Section 7). Transfus Apher Sci. 2010 Aug; 43(1):107-16.
  31. Slichter SJ, Kaufman RM, Assmann SF, McCullough J, Triulzi DJ, Strauss RG, Gernsheimer TB, Ness PM, Brecher ME, Josephson CD, Konkle BA, Woodson RD, Ortel TL, Hillyer CD, Skerrett DL, McCrae KR, Sloan SR, Uhl L, George JN, Aquino VM, Manno CS, McFarland JG, Hess JR, Leissinger C, Granger S. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med. 2010 Feb 18; 362(7):600-13.
  32. Sloan, Steven R. Hemolytic Anemia. Essential Evidence, M. Ebell editor. 2010.
  33. Sanchez R, Sloan SR, Josephson CD, Ambruso DR, Hillyer CD, O'Sullivan P. Consensus recommendations of pediatric transfusion medicine objectives for clinical pathology residency training programs. Transfusion. 2010 May; 50(5):1071-8.
  34. Gordon DJ, Sloan SR, de Jong JL. A pediatric case series of acute hemolysis after administration of intravenous immunoglobulin. Am J Hematol. 2009 Nov; 84(11):771-2.
  35. Hillyer CD, Mondoro TH, Josephson CD, Sanchez R, Sloan SR, Ambruso DR. Pediatric transfusion medicine: development of a critical mass. Transfusion. 2009 Mar; 49(3):596-601.
  36. Westhoff CM, Sloan SR. Molecular genotyping in transfusion medicine. Clin Chem. 2008 Dec; 54(12):1948-50.
  37. Higgins J, Sloan S. A stochastic model of RBC alloimmunization suggests a distinct population of "Responders". Transfusion. 2008; 48(2):9A.
  38. Higgins J, Sloan S. Does one antibody lead to another? Patterns in RBC alloantibody formation. Transfusion. 2008; 48(2):176A.
  39. Higgins JM, Sloan SR. Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders. Blood. 2008 Sep 15; 112(6):2546-53.
  40. Sloan SR. Technical issues in neonatal transfusions. Immunohematology. 2008; 24(1):4-9.
  41. Sloan, Steven R. Blood Products Used in the Newborn. Manual of Neonatal Care, Cloherty JP, Eichenwald EC, and Stark AR, editors. 2008; 463-469.
  42. Higgins JM, Sloan SR. Relative immunogenic strengths of RBC antigens in a pediatric poplulation. Transfusion. 2007; 47(3):163A-164A.
  43. Kaufman, RM Sloan, SR. Transfusion in bone marrow and solid organ transplant recipients. Blood Banking and Transfusion Medicine. 2006.
  44. Roseff SD, editor. Eder A, Hume H, Pisciotto P, Sloan S, Strauss R, contributing editors. Pediatric Transfusion; A Physician's Handbook. 2006; 208.
  45. Mauriello T, Wills R, Beaton M, Sloan R. LDL apheresis treatment in a pregnant woman wiht homozygous familial hypercholesterolemia. Transfusion. 2005; 45(3):38A.
  46. Cavanaugh PA, Doherty J, Beaton M, Sloan S. Transfusion reactions in a pediatric hospital. Transfusion. 2005; 45(3):110A.
  47. Haspel RL, Walsh L, Sloan SR. Risk of Rh(D) alloimmunization after transfusion of platelets from D+ donors to D- recipients - Reply. Transfusion. 2005; 45(3):453-454.
  48. Conlan MG, Stassinopoulos A, Garratty G, Wages D, Corash L, Wood L, Sloan SR, Labotka RJ. Antibody Formation to S-303-Treated RBCS in the Setting of Chronic RBC Transfusion. Blood. 2004; 104(11):382.
  49. Willis R, Beaton M, Sloan S, Miller D, Dummer CW, Rogers M, Cox D. A Multi-Site Method Comparison Trial Using the Critscan Hematocrit Measuring Device. Transfusion. 2004; 44(9S):10A.
  50. Framil RC, Doherty J, Beaton M, Sloan S. Inventory Management Challenges in a Pediatric Hospital with a 100% Irradiation Policy. Transfusion. 2004; 44(9S):107A.
  51. Boyd J, Sloan S, Meffert J. Elephantiasis nostrum verrucosa of the abdomen: clinical results with tazarotene. J Drugs Dermatol. 2004 Jul-Aug; 3(4):446-8.
  52. Haspel RL, Walsh L, Sloan SR. Platelet transfusion in an infant leading to formation of anti-D: implications for immunoprophylaxis. Transfusion. 2004 May; 44(5):747-9.
  53. Kao GS, Sloan SR. Peripheral Blood Stem Cells. Hillyer CD, Strauss RG, Luban NLC, editors. Handbook of Pediatric Transfusion Medicine. 2004; 283-293.
  54. Kao G, Sloan SR. Bone Marrow-Derived Stem Cells. Hillyer CD, Strauss RG, Luban NLC, editors. Handbook of Pediatric Transfusion Medicine. 2004; 271-281.
  55. Sloan SR. Blood Products Used in the Newborn. Cloherty JP, Eichenwald EC, Stark AR, editors. Manual of Neonatal Care. 2004; 487-492.
  56. Lu J, Honczarenko M, Sloan SR. Independent expression of the two paralogous CCL4 genes in monocytes and B lymphocytes. Immunogenetics. 2004 Jan; 55(10):706-11.
  57. Cunningham, M.J., Sloan, S.R. Minimizing Autologous Peripheral Leukapheresis Procedures for Pediatric Neuroblastoma Patients. Blood. 2003; 102(11):3027.
  58. Silberstein LE, Sloan SR, Doherty J, Beaton M, Kenny F, Woodbury C, Hall JA. Pan-genera Detection of Bacterial Contamination in Platelet Units. Transfusion. 2003; 43(9S):48A.
  59. Sloan SR, Silberstein LE. Transfusion Medicine. Furie B, Cassileth PA, Atkins MB, Mayer RJ, editors. Clinical Hematology and Oncology: Presentation, Diagnosis, and Treatment. 2003; 431-440.
  60. Sloan SR, Benjamin RJ, Friedman DE, Webb IJ, Silberstein L. Transfusion Medicine. Nathan DG, Orkin SH, Ginsburg D, Look AT, editors. Nathan and Oski's Hematology of Infancy and Childhood. 2003; 1709-1756.
  61. Roseff SD, editor. Chambers L, Eder A, Pisciotto P, Sloan S, Strauss R, contributing editors. Pediatric Transfusion: A Physician's Handbook. 2003.
  62. Doherty J, Parr M, Larrivee A, Beaton M, Sloan SR. Testing Non-group-O Neonates for Passively Acquired ABO Antibodies: Is 4 Months too Old?. Transfusion. 2002; 42(9S):96S.
  63. Lu J, Sloan SR. The basic helix-loop-helix domain of the E47 transcription factor requires other protein regions for full DNA binding activity. Biochem Biophys Res Commun. 2002 Feb 08; 290(5):1521-8.
  64. Lu J, Sloan SR. Phage-displayed antibodies to detect cell markers. Methods Mol Biol. 2002; 185:381-92.
  65. Willis, R.L., Beaton, M.A.,Sloan, S.R. Collaboration among all Donor Center Staff Improves Recruitment and Collections. Transfusion. 2001; 41(9S):AP25.
  66. Zubair, A.C., Beaton, M.A., Sloan, S.R. RBC T Activation and Severe Hemolysis in a Three-Month Old Infant. Transfusion. 2001; 41(9S):SP192.
  67. Sloan SR, Jefferies L. Evaluation and Management of Transfusion Reactions. Lanken PN, Hanson CW, Manaker S, editors. The Intensive Care Unit Manual. 2001; 531-539.
  68. Sloan SR. Peripheral-Blood-Derived Hematopoietic Progenitor Cells. Hillyer CD, Hillyer KL, Strobl FJ, Jefferies LC, Silberstein LE, editors. Handbook of Transfusion Medicine. 2001; 161-170.
  69. Sloan SR. Book Review: Phage Display: A Laboratory Manual. The Quarterly Review of Biology. 2001; 76:487-488.
  70. Lu J, Sloan SR. Phage Displayed Antibodies to Detect Cell Markers. Methods in Molecular Biology: Embryonic Stem Cells Methods and Protocols. 2001; 185:381-392.
  71. Sloan SR. Bone-Marrow Derived Hematopoetic Progenitor Cells. Hillyer CD, Hillyer KL, Strobl FJ, Jefferies LC, Silberstein LE, editors. Handbook of Transfusion Medicine. 2001; 149-159.
  72. Cinat ME, Wallace WC, Nastanski F, West J, Sloan S, Ocariz J, Wilson SE. Improved survival following massive transfusion in patients who have undergone trauma. Arch Surg. 1999 Sep; 134(9):964-8; discussion 968-70.
  73. Lu J, Sloan SR. An alternating selection strategy for cloning phage display antibodies. J Immunol Methods. 1999 Aug 31; 228(1-2):109-19.
  74. Wallace WC, Burchell, Ocariz J, Sloan S, West J, Cinat ME. Improved survival in trauma patients receiving massive transfusion. Critical Care Medicine. 1999; 27(1):A176.
  75. Sloan SR. Diseases associated with the major histocompatibility complex. West J Med. 1997 Jul; 167(1):36-7.
  76. Sloan SR, Silberstein L. Transfusion in the face of Autoantibodies. Reid ME, Nance SJ, editors. Red Blood Cell Transfusions: A Practical Guide. 1997.
  77. Sloan SR, Shen CP, McCarrick-Walmsley R, Kadesch T. Phosphorylation of E47 as a potential determinant of B-cell-specific activity. Mol Cell Biol. 1996 Dec; 16(12):6900-8.
  78. Sloan, S.R., Shen, C., Kadesch, T. Hypophosphorylation of the Human E2A protein results in a B cell specific transcription factor. Transfusion. 1995; 35(10S):39S.
  79. Kamoun M, Zerva L, Sloan S, Zmijewski C, Monos D, Trinchieri G. Induction of HLA class II molecules on human T cells: relationship to immunoregulation and the pathogenesis of AIDS. DNA Cell Biol. 1992 Apr; 11(3):265-8.
  80. Sloan SR, Pellicer A. Activation of the ras oncogene in gamma radiation and neutron radiation induced thymic lymphomas. Prog Clin Biol Res. 1992; 374:1-18.
  81. Sloan SR, Pellicer A. Activation of the ras oncogene in gamma radiation and neutron radiation induced thymic lymphomas. Relevance of Animal Studies to Evaluation of Human Cancer Risk. 1992; 1-18.
  82. Sloan SR, Pellicer A. Ras oncogene activation in gamma- and neutron- radiation induced murine thymic lymphomas. Dewey WC, Edington M, Fry RJM, Hall EJ, Whitmore GF, editors. 9th International Congress of Radiation Research. 1992; 353-357.
  83. Corominas M, Sloan SR, Leon J, Kamino H, Newcomb EW, Pellicer A. ras activation in human tumors and in animal model systems. Environ Health Perspect. 1991 Jun; 93:19-25.
  84. Sloan SR, Pellicer A. Staging of T-cell receptor beta chain gene rearrangements and ras oncogene mutations in the development of murine thymic lymphomas. Cancer Res. 1991 Mar 15; 51(6):1627-31.
  85. Sloan SR, Pellicer A. Oncogene activation in radiation induced tumors. 1991 Annual Meeting of the National Council of Radiation Protection and Measurements. 1991.
  86. Sloan SR, Newcomb EW, Pellicer A. Neutron radiation can activate K-ras via a point mutation in codon 146 and induces a different spectrum of ras mutations than does gamma radiation. Mol Cell Biol. 1990 Jan; 10(1):405-8.
  87. Newcomb EW, Diamond LE, Sloan SR, Corominas M, Guerrerro I, Pellicer A. Radiation and chemical activation of ras oncogenes in different mouse strains. Environ Health Perspect. 1989 May; 81:33-7.
  88. Diamond LE, Sloan SR, Pellicer A, Hayday AC. T-cell receptor gene rearrangement in primary tumors: effect of genetic background and inducing agent. Immunogenetics. 1988; 28(2):71-80.
  89. Weaver JC, Mintzer RA, Ling H, Sloan SR. Conduction Onset Criteria for Transient Aqueous Pores and Reversible Electrical Breakdown in Bilayer-Membranes. Bioelectrochemistry and Bioenergetics. 1986; 15(2):229-241.
  90. Weaver JC, Powell KT, Mintzer RA, Ling H, Sloan SR. The Electrical Capacitance of Bilayer-Membranes the Contribution of Transient Aqueous Pores. Bioelectrochemistry and Bioenergetics. 1984; 12(3-4):393-404.
  91. Weaver JC, Powell KT, Mintzer RA, Sloan SR, Ling H. Bis-The Diffuse Permeability of Bilayer-Membranes the Contribution of Transient Aqueous Pores. Bioelectrochemistry and Bioenergetics. 1984; 12(3-4):405-412.
  92. Sandor T, Sloan S, D’Adamo AJ, Boxt LM, Harrington DP, Spears JR, Paulin S. Automation of Left Ventricular Contour Detection. Proceedings of the Society of Photo-Optical Instrumentation Engineers. 1984; 454:197-206.
  93. Sandor T, Sloan S, Dadamo AJ, Boxt LM, Harrington DP, Spears JR, Paulin S. Automation of Left-Ventricular Contour-Detection. Proceedings of the Society of Photo-Optical Instrumentation Engineers. 1984; 454:197-206.
To schedule an appointment: Call 617-355-6347


Boston Children’s is so much more than a hospital—it’s a community of researchers, clinicians, administrators, support staff, innovators, teachers, patients and families, all working together to make the impossible possible. ”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital
300 Longwood Avenue, Boston, MA 02115
For Patients: 617-355-6000
For Referring Providers: 844-BCH-PEDS | 844-224-7337